2. Exhibit A

The courtroom of the Federal District Court for the District of Avalon smelled of old paper and floor wax, a combination that Leo Sterling had once found reassuring and now found suffocating. Judge Helena Forsythe presided from a bench of dark walnut, her spectacles perched at the tip of her nose, her expression as unreadable as a shuttered window. The gallery was sparse—five journalists, three patent analysts, and a young woman sketching the proceedings in charcoal. Vivienne had offered to attend, but Leo had insisted she stay home. He told himself it was to shield her from the press. The deeper truth was simpler and more troubling: he did not want her in the same room as the evidence he was about to face.

Celeste Valcourt, OmniVax’s lead counsel, sat to Leo’s left, her silver-streaked hair pulled into a severe bun that somehow made her look more formidable rather than less. She had been defending pharmaceutical patents for thirty years, and her face had the weathered composure of someone who had seen guilt disguised as invention too many times to count. She touched Leo’s elbow and leaned close. “Remember what we discussed. Whatever they show, your face remains neutral. The jury is watching your reaction, not the document.”

Leo nodded, his jaw tight.

Opposing counsel, Aaron Keating of Praxis Biologics, was a slender man with the theatrical flair of a stage actor. He adjusted his cuffs as he approached the lectern, a single sheet of paper enclosed in a clear evidence sleeve held between two fingers. The sleeve caught the overhead light and threw a sharp rectangle of glare across the mahogany table.

“Your Honor, the defense moves to admit Exhibit A,” Keating said, his voice pitched for the back row. “A page extracted from OmniVax’s confidential laboratory notebook, numbered zero-zero-four-seven, dated March fourteenth of last year. This page was submitted to the court under seal last evening after being authenticated by an independent forensic document examiner.”

Judge Forsythe lowered her spectacles. “Any objection, Ms. Valcourt?”

“Objection, Your Honor, on grounds of chain of custody and authentication. The provenance of this document is unknown. It appears to have been leaked from our client’s secure facility, which constitutes a breach of confidentiality and possibly a criminal act.”

“Your Honor,” Keating interjected smoothly, “the defense received this document from a whistleblower who wishes to remain anonymous. Chain of custody has been documented from the moment of receipt. The forensic examiner’s report is included with our submission. The document speaks directly to the validity of OmniVax’s patent claims.”

Forsythe tapped her pen on the bench. “Overruled, with the caveat that Ms. Valcourt may challenge the document’s weight during cross-examination. Proceed, Mr. Keating.”

Keating placed the evidence sleeve on the overhead projector, and the page bloomed onto the wall screen. The handwriting was cramped, precise, rendered in blue ink that had begun to fade toward violet at the edges. The top of the page bore the OmniVax letterhead and the words “Confidential — Lab Notebook 7, Dr. Leo Sterling.” Below that, a table of numbers: antibody concentrations, binding affinities, and a final column labeled “Inhibition Percentage.” The figures in the final column were uniformly above ninety-eight percent—implausibly high, the kind of perfect data that real experiments almost never produce.

Leo felt a cold weight settle in his stomach. He recognized the notebook’s format, the type of pen he used, even the particular slant of the script. But the numbers themselves were wrong. The experiment described on that page had never produced those results. Someone had fabricated the data after the fact and copied his writing style with unsettling accuracy.

“This page purports to record the initial proof-of-concept assay for OmniVax’s PCSK9 antibody,” Keating said, gesturing at the screen. “As you can see, every single measurement falls within a statistical sweet spot that experienced scientists would call a red flag. No variation, no outliers, no evidence of genuine experimental uncertainty. The independent examiner, Dr. Margaret Zhou of the Avalon Institute of Forensic Science, has concluded that the handwriting on this page matches Dr. Sterling’s known exemplars with ninety-four percent probability.”

Celeste was already on her feet. “Ninety-four percent is not one hundred percent, Your Honor. Dr. Zhou’s own report acknowledges that skilled forgers can achieve high-confidence matches under certain conditions.”

“Which is precisely why we are presenting this evidence in open court,” Keating replied. “So that the jury may weigh the totality of the circumstances. This notebook page, taken alongside OmniVax’s unusually rapid antibody discovery timeline and their refusal to share raw data with the patent office, paints a picture of systematic fraud.”

Judge Forsythe removed her spectacles and pinched the bridge of her nose. Leo watched her face, searching for a signal, but she revealed nothing. She had been a patent attorney herself before ascending to the bench, and she understood better than most the high stakes involved. OmniVax’s antibody, if validated, would capture a market worth twelve billion dollars annually. Praxis’s competing drug had been trailing in clinical trials, and if OmniVax’s patent stood, Praxis would be locked out of the market for a decade.

“Ms. Valcourt,” Forsythe said, “can your client explain the provenance of this page? Specifically, who had access to the laboratory notebooks during the relevant timeframe?”

Celeste glanced at Leo. He gave a slight nod, and she turned back to the bench. “Three individuals, Your Honor. Dr. Sterling, his senior researcher Dr. Damien Croft, and Dr. Sterling’s wife, Vivienne Sterling, who served as OmniVax’s communications liaison and occasionally assisted with documentation.”

A murmur rippled through the gallery. Vivienne’s name had landed in the sterile air like a drop of ink in water. Keating seized on it instantly. “Vivienne Sterling, the social media personality? The woman who has been broadcasting her support for her husband’s company to millions of followers while simultaneously handling confidential laboratory documents?”

“Objection,” Celeste snapped. “Badgering and speculative.”

“Sustained,” Forsythe said. “Mr. Keating, you will refrain from characterizing witnesses who are not present. Save it for cross-examination.”

But the damage was done. The journalists were already scribbling notes, and Leo could feel the narrative taking shape around him: the charismatic founder, the beautiful wife, the leaked document, the whiff of scandal. It was the kind of story that the Avalon City press would devour in bites.

Forsythe shuffled her papers. “Given the seriousness of this allegation, I am issuing a preliminary injunction freezing OmniVax’s European sublicensing revenues pending a full hearing on the enablement question. Furthermore, I am ordering OmniVax to produce all laboratory notebooks, raw data files, and correspondence from the antibody development period within ten business days. Failure to comply will result in contempt sanctions.”

The gavel struck wood, and the sound echoed through Leo’s chest. He felt Celeste’s hand on his arm, guiding him toward the exit, but his legs felt disconnected from his body. The European revenues were OmniVax’s primary cash flow; without them, payroll for three hundred employees would be compromised within six weeks. The company was bleeding, and someone had handed Praxis the knife.

In the hallway, Celeste steered him into a private conference room and closed the door. The walls were lined with law books no one ever opened, their spines pristine and uniform. She did not sit.

“Someone inside your company gave Praxis that page,” she said, her voice low and urgent. “It’s not just a leak; it’s a surgical strike. Whoever did this knew exactly which experiment to target, exactly which data would look most suspicious when taken out of context.”

“Croft,” Leo said, the name scraping his throat.

“Croft is the obvious candidate, yes. But you need to consider the possibility that it isn’t Croft. Your wife had access to those notebooks. I need to ask you a question, and I need you to answer honestly. Is there any scenario—any at all—where Vivienne could have been involved?”

Leo thought of the glitch frame. The frozen image of his wife’s eyes, drained of warmth, staring out from the monitor like a warning from another dimension. He had not told Celeste about it. He had not told anyone. To speak it aloud would be to give it a shape it did not yet deserve, to summon a monster that might not exist.

“No,” he said. “Vivienne would never do that. She has no motive. She has no connection to Praxis.”

Celeste studied him for a long moment, then nodded. “Then we focus on Croft. Your investigator—Malkin—she’s good?”

“The best.”

“Tell her to dig deeper. Look for financial connections, hidden accounts, anything that ties Croft to Praxis. And tell her to do it fast. The clock is ticking.”

Leo left the courthouse through a side exit, avoiding the cluster of reporters camped at the main doors. The Avalon City sky was the color of a bruise, low clouds threatening rain. He climbed into the back of his black sedan and told the driver to take the long route home.

As the car wove through the financial district, Leo’s phone vibrated. A message from Vivienne: “I saw the news alert. Come home. We’ll get through this together. I love you.” He stared at the words, trying to read the space between them. The message was exactly what a loving wife would send. Perfectly appropriate, perfectly timed, perfectly empty.

He tapped a reply: “On my way.”

The penthouse was quiet when he arrived, the afternoon light filtering through the windows in long, dusty columns. Vivienne met him at the door in a simple grey dress, her hair pulled back, her face bare of makeup. She looked younger this way, more vulnerable, the version of herself that the cameras never captured. She wrapped her arms around him and held tight, her cheek pressed to his chest.

“I was so scared when I saw the news,” she whispered. “What did the judge say?”

“She froze the European revenues and ordered us to turn over all our notebooks.”

Vivienne pulled back, her eyes wide. “All of them? That’s years of work. There must be fifty notebooks in the archive.”

“Sixty-two. I counted this morning.”

She pressed her palms to her cheeks, a gesture of genuine distress. “Leo, this is my fault. I should have been more careful. I used to take the notebooks to the copy room sometimes when you asked me to prepare summaries. What if someone got to them while I was out of the room?”

“You’re not to blame. We have protocols. Croft had the primary responsibility for the clean room.”

“But what if it wasn’t Croft?” Vivienne’s voice trembled. “What if someone else in the company was working with Praxis? Someone I might have trusted?”

Leo watched her face carefully. The tremor in her voice, the clutch of her hands, the slight sheen of tears gathering at the rims of her eyes—it all read as authentic. But he had watched her perform for millions of people, and he knew how good she was.

“Who would you suspect?” he asked.

She hesitated, then shook her head. “I don’t know. That’s what terrifies me. Someone close to us, someone we see every day. The idea that we could share our lives with someone and never truly know them…” She broke off, her sentence dissolving into a shudder.

The irony was not lost on Leo. He pulled her close again, letting her bury her face in his shoulder, and stared over her head at the bank of security monitors in the hallway. The screens showed empty rooms, empty corridors, the silent machinery of a home built on trust.

That evening, Leo excused himself to the study under the pretext of reviewing case files. He locked the door and opened his safe, removing the external drive containing the raw stream footage. He watched frame 58207 again, then advanced to frame 58208, then back. The glitch was unmistakable. The woman in that frozen moment was not the woman who had held him in the hallway.

He opened a search browser and typed: “Vivienne Sterling biography before OmniVax.” The results were sparse. She had worked as a pharmaceutical sales representative for a small company called NorthStar Medical before transitioning to a lifestyle influencer role. There was a two-year gap between her departure from NorthStar and her emergence on social media. She had described those years as a period of “self-discovery and travel.”

Leo scrolled deeper. On the third page of results, he found a scanned newsletter from a charity gala held six years earlier by Praxis Biologics. The newsletter included a group photograph of attendees, and in the third row, slightly blurred, stood a young woman with amber eyes and a familiar tilt to her chin. The caption listed her as “Vivienne Duvall, NorthStar Medical Representative.”

She had attended a Praxis event years before she met Leo. She had never mentioned it. It was a small thing, a footnote, the kind of detail that any reasonable person would dismiss as a coincidence.

But Leo was no longer a reasonable person. He saved the image to the encrypted drive and closed the browser. Then he sent a message to Sara Malkin: “Expand the background check to include Praxis-related events prior to our marriage. I need to know everything.”

His phone buzzed a moment later with her reply: “Understood. Meet me tomorrow. I’ve found something on Croft that you need to see.”

Leo stared at the message, the cursor blinking beside it. Somewhere in the penthouse, Vivienne was preparing dinner, humming a tune he could not quite place. The sound drifted through the walls like smoke, faint and formless, and for the first time in his marriage, he did not feel comforted by it.

He felt hunted.